AEOI to Play More Active Role in Iran’s Health Sector: Official
TEHRAN (Tasnim) – The Atomic Energy Organization of Iran (AEOI) plans to upgrade the country’s medical capabilities by employing nuclear technology, AEOI chief announced.
Head of the AEOI Ali Akbar Salehi announced on Sunday that his organization has set an agenda for “broadening the boundaries of knowledge and upgrading the existing capabilities in diverse sectors in the health sector”.
Speaking in a ceremony held to unveil three new achievements of the AEOI, Salehi underlined that the country’s nuclear industry has in recent years succeeded to produce a range of radio medicines for the medical centers.
During the ceremony, Iranian President Hassan Rouhani unveiled the three cutting-edge products of the AEOI.
The products include a tubular centrifuge, which is used for the production of recombinant human and veterinary vaccines, an ultraviolet radiation monitoring system, and the national multi-purpose gamma irradiation system.
In December 2013, AEOI Spokesperson Behrouz Kamalvandi had announced that fifteen types of nano medicines are produced in Iran.
“Such great achievements prove that science is not monopolized by a few countries, and that self-reliance can lead to astonishing successes," he said at the time.
And later in April, Iran unveiled two other new achievements in the area of nuclear technology, namely a state-of-the-art control room for the Tehran Research Reactor plus an oxygen 18 production unit at Arak site.